Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Weilert

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Gastrointestinal Endoscopy|February 25, 2014
EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative studyFrank Weilert, Yasser M Bhat, Kenneth F Binmoeller, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 5, 2026
Cost-Effectiveness and Efficacy of Biodegradable Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Retrospective Multi-Center StudyVicki McGarrigle, Yuto Shimamura, Leonardo Zorron Cheng Tao Pu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2010
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patientsEdward J Gane, Frank Weilert, David W Orr, et al.
Journal of Hepatology|March 13, 2019
Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infectionDavid Wyles, Ola Weiland, Betty Yao, et al.
Gastroenterology|January 10, 2019
Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV InfectionMan Fung Yuen, Edward J Gane, Dong Joon Kim, et al.
Hepatology (Baltimore, Md.)|September 20, 2017
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trialDavid Wyles, Fred Poordad, Stanley Wang, et al.
DEN Open|July 6, 2026
Clinical Outcomes of Colorectal Endoscopic Full-Thickness Resection Using the Full-Thickness Resection Device: A Multicenter StudyVicki McGarrigle, Yuto Shimamura, Leonardo Zorron Cheng Tao Pu, et al.
Gastrointestinal Endoscopy|May 10, 2025
Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity-score weighted landmark analysisAmanda H Lim, Darshan Nitchingham, Jana Bednarz, et al.
The New England Journal of Medicine|December 5, 2008
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis BPatrick Marcellin, E Jenny Heathcote, Maria Buti, et al.
Gastroenterology|October 20, 2010
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis BE Jenny Heathcote, Patrick Marcellin, Maria Buti, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Gastrointestinal Endoscopy|February 25, 2014
EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative studyFrank Weilert, Yasser M Bhat, Kenneth F Binmoeller, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 5, 2026
Cost-Effectiveness and Efficacy of Biodegradable Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Retrospective Multi-Center StudyVicki McGarrigle, Yuto Shimamura, Leonardo Zorron Cheng Tao Pu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2010
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patientsEdward J Gane, Frank Weilert, David W Orr, et al.
Journal of Hepatology|March 13, 2019
Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infectionDavid Wyles, Ola Weiland, Betty Yao, et al.
Gastroenterology|January 10, 2019
Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV InfectionMan Fung Yuen, Edward J Gane, Dong Joon Kim, et al.
Hepatology (Baltimore, Md.)|September 20, 2017
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trialDavid Wyles, Fred Poordad, Stanley Wang, et al.
DEN Open|July 6, 2026
Clinical Outcomes of Colorectal Endoscopic Full-Thickness Resection Using the Full-Thickness Resection Device: A Multicenter StudyVicki McGarrigle, Yuto Shimamura, Leonardo Zorron Cheng Tao Pu, et al.
Gastrointestinal Endoscopy|May 10, 2025
Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity-score weighted landmark analysisAmanda H Lim, Darshan Nitchingham, Jana Bednarz, et al.
The New England Journal of Medicine|December 5, 2008
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis BPatrick Marcellin, E Jenny Heathcote, Maria Buti, et al.
Gastroenterology|October 20, 2010
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis BE Jenny Heathcote, Patrick Marcellin, Maria Buti, et al.
Pageof 5